Silent Myocardial Ischemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-05-17
Clinical Trial Update: Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics [NA]
The clinical trial evaluating whether ranolazine reduces biomarkers of myocardial damage in patients with silent myocardial ischemia and typ…